Insmed to Host First Quarter 2018 Financial Results Conference Call on Wednesday, May 2, 2018
April 25, 2018 08:00 ET
|
Insmed, Inc.
BRIDGEWATER, N.J., April 25, 2018 (GLOBE NEWSWIRE) -- Insmed Incorporated (Nasdaq:INSM), a global biopharmaceutical company focused on the unmet needs of patients with rare diseases, today announced...
Insmed Submits New Drug Application to FDA for ALIS in NTM Lung Disease Caused by MAC
March 29, 2018 08:00 ET
|
Insmed, Inc.
ALIS previously designated as an orphan drug, breakthrough therapy and Qualified Infectious Disease Product (QIDP) BRIDGEWATER, N.J., March 29, 2018 (GLOBE NEWSWIRE) -- Insmed...
Insmed to Present at the Cowen and Company 38th Annual Health Care Conference
March 07, 2018 08:00 ET
|
Insmed, Inc.
BRIDGEWATER, N.J., March 07, 2018 (GLOBE NEWSWIRE) -- Insmed Incorporated (Nasdaq:INSM), a global biopharmaceutical company focused on the unmet needs of patients with rare diseases, today announced...
Insmed Reports Fourth Quarter and Full Year 2017 Financial Results and Provides Business Update
February 23, 2018 07:30 ET
|
Insmed, Inc.
On track to file NDA before the end of March and anticipate a priority reviewExtended amikacin liposome inhalation suspension (ALIS) intellectual property protection to 2035 with issuance of ninth...
Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
February 21, 2018 17:26 ET
|
Insmed, Inc.
BRIDGEWATER, N.J., Feb. 21, 2018 (GLOBE NEWSWIRE) -- Insmed Incorporated (Nasdaq:INSM), a global biopharmaceutical company focused on the unmet needs of patients with rare diseases, today announced...
Insmed Extends ALIS Intellectual Property Protection to 2035 with Issuance of Ninth U.S. Patent
February 20, 2018 08:00 ET
|
Insmed, Inc.
BRIDGEWATER, N.J., Feb. 20, 2018 (GLOBE NEWSWIRE) -- Insmed Incorporated (Nasdaq:INSM), a global biopharmaceutical company focused on the unmet needs of patients with rare diseases, today announced...
Insmed to Host Fourth Quarter and Full Year 2017 Financial Results Conference Call on Friday, February 23, 2018
February 15, 2018 08:00 ET
|
Insmed, Inc.
BRIDGEWATER, N.J., Feb. 15, 2018 (GLOBE NEWSWIRE) -- Insmed Incorporated (Nasdaq:INSM), a global biopharmaceutical company focused on the unmet needs of patients with rare diseases, today announced...
Insmed to Present at the Leerink Partners 7th Annual Global Healthcare Conference
February 07, 2018 16:30 ET
|
Insmed, Inc.
BRIDGEWATER, N.J., Feb. 07, 2018 (GLOBE NEWSWIRE) -- Insmed Incorporated (Nasdaq:INSM), a global biopharmaceutical company focused on the unmet needs of patients with rare diseases, today announced...
Insmed Announces Closing of Public Offering
January 26, 2018 12:00 ET
|
Insmed, Inc.
BRIDGEWATER, N.J., Jan. 26, 2018 (GLOBE NEWSWIRE) -- Insmed Incorporated (Nasdaq:INSM) announced the closing today of its previously announced public offering of its 1.75% convertible senior notes...
Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
January 24, 2018 17:31 ET
|
Insmed, Inc.
BRIDGEWATER, N.J., Jan. 24, 2018 (GLOBE NEWSWIRE) -- Insmed Incorporated (Nasdaq:INSM), a global biopharmaceutical company focused on the unmet needs of patients with rare diseases, today announced...